Harvard Bioscience Sees Q3 Sales $21.000M-$22.600M vs $21.850M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q3 sales of $21.000 million-$22.600 million vs $21.850 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q3 sales of $21.000 million-$22.600 million vs $21.850 million analyst estimate.